{"action":"elsewhere","city":"Wilmington","companyRegistrationNumber":null,"conformityFlag":"NON_CONFORMING","country":"US","createdAt":"2016-08-04T00:00:00.000Z","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[{"active":true,"country":"US","legalName":"Bioverativ Therapeutics Inc.","lei":"549300FG1M08D5DJ1X84","relationshipTypes":["IS_DIRECTLY_CONSOLIDATED_BY"]}],"childrenTotal":1,"exceptions":[{"category":"DIRECT_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_PUBLIC"],"references":[]},{"category":"ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_PUBLIC"],"references":[]}],"parents":[]},"headquartersAddress":"225 Second Avenue","headquartersCity":"Waltham","headquartersCountry":"US","headquartersPostalCode":"02451","headquartersRegion":"US-MA","lastUpdatedAt":"2026-06-16T07:29:24.783Z","legalAddress":"C/O Corporation Service Company, 251 Little Falls Drive","legalFormAbbreviation":null,"legalFormCode":"XTIQ","legalFormName":"Corporation","legalJurisdiction":"US-DE","legalName":"Bioverativ Inc.","lei":"549300461Z3XXZQSI879","managingLou":"5493001KJTIIGC8Y1R12","managingLouName":"Bloomberg","managingLouWebsite":"http://lei.bloomberg.com","nextRenewalAt":"2018-12-16T00:31:00.000Z","otherLegalForm":null,"postalCode":"19808","region":"US-DE","registeredAt":"2016-12-17T01:53:00.000Z","registrationAuthorityId":"RA000602","registrationAuthorityName":"Division of Corporations, Department of State","registrationAuthorityWebsite":"https://corp.delaware.gov/","registrationNumber":"6108613","registrationNumberFormatted":"6108613","registrationStatus":"LAPSED","served":false,"successorLeis":[],"validationAuthorityEntityId":"6108613","validationAuthorityId":"RA000602","validationAuthorityName":"Division of Corporations, Department of State","validationSources":"FULLY_CORROBORATED"}